BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1146 related articles for article (PubMed ID: 19714720)

  • 1. Chronic hepatitis B: update 2009.
    Lok AS; McMahon BJ
    Hepatology; 2009 Sep; 50(3):661-2. PubMed ID: 19714720
    [No Abstract]   [Full Text] [Related]  

  • 2. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.
    European Association For The Study Of The Liver
    J Hepatol; 2012 Jul; 57(1):167-85. PubMed ID: 22436845
    [No Abstract]   [Full Text] [Related]  

  • 3. AASLD guidelines for treatment of chronic hepatitis B.
    Terrault NA; Bzowej NH; Chang KM; Hwang JP; Jonas MM; Murad MH;
    Hepatology; 2016 Jan; 63(1):261-83. PubMed ID: 26566064
    [No Abstract]   [Full Text] [Related]  

  • 4. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
    Liaw YF; Kao JH; Piratvisuth T; Chan HL; Chien RN; Liu CJ; Gane E; Locarnini S; Lim SG; Han KH; Amarapurkar D; Cooksley G; Jafri W; Mohamed R; Hou JL; Chuang WL; Lesmana LA; Sollano JD; Suh DJ; Omata M
    Hepatol Int; 2012 Jun; 6(3):531-61. PubMed ID: 26201469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection.
    Trépo C; Chan HL; Lok A
    Lancet; 2014 Dec; 384(9959):2053-63. PubMed ID: 24954675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
    Ott JJ; Stevens GA; Groeger J; Wiersma ST
    Vaccine; 2012 Mar; 30(12):2212-9. PubMed ID: 22273662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatocellular carcinoma: an update.
    Bruix J; Sherman M;
    Hepatology; 2011 Mar; 53(3):1020-2. PubMed ID: 21374666
    [No Abstract]   [Full Text] [Related]  

  • 9. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
    Reddy KR; Beavers KL; Hammond SP; Lim JK; Falck-Ytter YT;
    Gastroenterology; 2015 Jan; 148(1):215-9; quiz e16-7. PubMed ID: 25447850
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
    Marcellin P; Gane E; Buti M; Afdhal N; Sievert W; Jacobson IM; Washington MK; Germanidis G; Flaherty JF; Aguilar Schall R; Bornstein JD; Kitrinos KM; Subramanian GM; McHutchison JG; Heathcote EJ
    Lancet; 2013 Feb; 381(9865):468-75. PubMed ID: 23234725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Núñez M
    Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
    [No Abstract]   [Full Text] [Related]  

  • 12. Sexually transmitted diseases treatment guidelines, 2015.
    Workowski KA; Bolan GA;
    MMWR Recomm Rep; 2015 Jun; 64(RR-03):1-137. PubMed ID: 26042815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with hepatitis B who require immunosuppressive therapy.
    Hwang JP; Lok AS
    Nat Rev Gastroenterol Hepatol; 2014 Apr; 11(4):209-19. PubMed ID: 24247262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
    Terrault NA; Lok ASF; McMahon BJ; Chang KM; Hwang JP; Jonas MM; Brown RS; Bzowej NH; Wong JB
    Hepatology; 2018 Apr; 67(4):1560-1599. PubMed ID: 29405329
    [No Abstract]   [Full Text] [Related]  

  • 15. Microscopic colitis.
    Pardi DS; Kelly CP
    Gastroenterology; 2011 Apr; 140(4):1155-65. PubMed ID: 21303675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.
    Lieberman DA; Rex DK; Winawer SJ; Giardiello FM; Johnson DA; Levin TR
    Gastroenterology; 2012 Sep; 143(3):844-857. PubMed ID: 22763141
    [No Abstract]   [Full Text] [Related]  

  • 17. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
    Sarin SK; Kumar M; Lau GK; Abbas Z; Chan HL; Chen CJ; Chen DS; Chen HL; Chen PJ; Chien RN; Dokmeci AK; Gane E; Hou JL; Jafri W; Jia J; Kim JH; Lai CL; Lee HC; Lim SG; Liu CJ; Locarnini S; Al Mahtab M; Mohamed R; Omata M; Park J; Piratvisuth T; Sharma BC; Sollano J; Wang FS; Wei L; Yuen MF; Zheng SS; Kao JH
    Hepatol Int; 2016 Jan; 10(1):1-98. PubMed ID: 26563120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
    Schweitzer A; Horn J; Mikolajczyk RT; Krause G; Ott JJ
    Lancet; 2015 Oct; 386(10003):1546-55. PubMed ID: 26231459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American College of Gastroenterology guideline: management of acute pancreatitis.
    Tenner S; Baillie J; DeWitt J; Vege SS;
    Am J Gastroenterol; 2013 Sep; 108(9):1400-15; 1416. PubMed ID: 23896955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
    JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.